Filed before 2025Filed 23 May 2024
Lycia Therapeutics, Inc. raised $107M
Lycia Therapeutics, Inc., a biotech company based in South San Francisco, CA, raised $107M in a new equity round, according to a filing dated 23 May 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 23 May 2024
- Round
- Equity round
- Amount sold
- $107M
- Offering size
- $107M
- Investors so far
- 16
- Based in
- South San Francisco, CA
- Website
- lyciatx.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 96% of the 1,434 tracked raises with an amount filed in 2024, and than 86% of the 138 in biotech.
Lycia Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 25 Jun 2026 | New filing | $75M | Another raise |
| 23 May 2024 | New filing | $107M | This raise |
| 16 Sep 2021 | New filing | $70.1M | Another raise |
| 17 Mar 2020 | New filing | $25.4M | Another raise |
More with Versant on the board
- Nexo Therapeutics, Inc.$60M
- Okami Medical, Inc.$28.9M
- VI1, Inc.$5M
- Rampart IC, Inc.$16.7M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.